Cargando…
Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227515/ https://www.ncbi.nlm.nih.gov/pubmed/35746664 http://dx.doi.org/10.3390/v14061193 |
| _version_ | 1784734199712841728 |
|---|---|
| author | Vaillant, Andrew |
| author_facet | Vaillant, Andrew |
| author_sort | Vaillant, Andrew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9227515 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92275152022-06-25 Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development? Vaillant, Andrew Viruses Editorial MDPI 2022-05-31 /pmc/articles/PMC9227515/ /pubmed/35746664 http://dx.doi.org/10.3390/v14061193 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Editorial Vaillant, Andrew Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development? |
| title | Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development? |
| title_full | Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development? |
| title_fullStr | Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development? |
| title_full_unstemmed | Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development? |
| title_short | Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development? |
| title_sort | targeting subviral particles: a critical step in achieving hbv functional cure but where are we with current agents in clinical development? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227515/ https://www.ncbi.nlm.nih.gov/pubmed/35746664 http://dx.doi.org/10.3390/v14061193 |
| work_keys_str_mv | AT vaillantandrew targetingsubviralparticlesacriticalstepinachievinghbvfunctionalcurebutwherearewewithcurrentagentsinclinicaldevelopment |